Cargando…

Does Single Computed Tomography Attenuation Correction able to Surrogate Serial Computed Tomography Attenuation Correction in Single-Photon Emission Computed Therapy Imaging for Peptide Receptor Radionuclide Therapy Dosimetry Result?

Peptide Receptor Radionuclide Therapy (PRRT) is the administration of a radionuclide, such as the Lu-177 label, along with a pharmaceutical agent to destroy the lesion cell. The first cycle of Lu-177 DOTA-TATE is an excellent way to estimate radionuclide uptake for organs at risk. To estimate the ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Said, Mohamad Aminudin Bin, Razak, Hairil Rashmizal Abdul, Musarudin, Marianie Bnti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543000/
https://www.ncbi.nlm.nih.gov/pubmed/36212205
http://dx.doi.org/10.4103/jmp.jmp_82_21
_version_ 1784804274468814848
author Said, Mohamad Aminudin Bin
Razak, Hairil Rashmizal Abdul
Musarudin, Marianie Bnti
author_facet Said, Mohamad Aminudin Bin
Razak, Hairil Rashmizal Abdul
Musarudin, Marianie Bnti
author_sort Said, Mohamad Aminudin Bin
collection PubMed
description Peptide Receptor Radionuclide Therapy (PRRT) is the administration of a radionuclide, such as the Lu-177 label, along with a pharmaceutical agent to destroy the lesion cell. The first cycle of Lu-177 DOTA-TATE is an excellent way to estimate radionuclide uptake for organs at risk. To estimate the absorbed dose for a kidney, serial SPECT-CT imaging with up to five sets is required. In general, serial CT on patients would result in additional external exposure and extra time consuming, especially for low dose CT such as cone beam CT technology. However, by introducing a new method, such as optimized single CT (24 h) to perform with serial SPECT attenuation correction, additional external exposure from serial CT exposure could be reduced. AIMS: The purpose of this study is to assess the agreement between single CT scanning as CT attenuation Correction with serial CT scanning for serial SPECT imaging as well as estimated absorbed dose to the organ at risk. SETTINGS AND DESIGN: During the first cycle of Lu177-DOTA-TATE, all patients should undergo internal dosimetry technique using SPECT-CT imaging with a PHILIP Brightview XCT gamma camera. The quantifications of SPECT images are being used to measure the uptake activity to the organ. In this investigation, Partik's categorical grading criteria are being used to convert the numeric value of Lin's concordance coefficient into an ordinal scale. METHOD: Total of 9 patients at our institution was administered with Lu177-DOTA-TATE enroll in this study. SPECT-CT data were acquired using automatic body contouring with a total of 48 angular views at steps of 6° (15 s/projections). The pixel size is 4.66 x 4.66 x 4.66 mm, the images size set to one, and SPECT data has been acquired for three-bed positions extending from the abdomen to the thorax region. Low-dose CT imaging performed at an X-ray tube voltage of 120 kVp. RESULTS: Our current result demonstrated by single CT scanning for SPECT attenuation shown the excellent agreement with standard serial CT imaging for organs at risk such as kidney 0.999, spleen 0.9951, liver 0.9951 and bladder 0.9972. CONCLUSIONS: When compared to the previous method, patients benefit significantly more from this study, such as lower CT exposure.
format Online
Article
Text
id pubmed-9543000
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-95430002022-10-08 Does Single Computed Tomography Attenuation Correction able to Surrogate Serial Computed Tomography Attenuation Correction in Single-Photon Emission Computed Therapy Imaging for Peptide Receptor Radionuclide Therapy Dosimetry Result? Said, Mohamad Aminudin Bin Razak, Hairil Rashmizal Abdul Musarudin, Marianie Bnti J Med Phys Original Article Peptide Receptor Radionuclide Therapy (PRRT) is the administration of a radionuclide, such as the Lu-177 label, along with a pharmaceutical agent to destroy the lesion cell. The first cycle of Lu-177 DOTA-TATE is an excellent way to estimate radionuclide uptake for organs at risk. To estimate the absorbed dose for a kidney, serial SPECT-CT imaging with up to five sets is required. In general, serial CT on patients would result in additional external exposure and extra time consuming, especially for low dose CT such as cone beam CT technology. However, by introducing a new method, such as optimized single CT (24 h) to perform with serial SPECT attenuation correction, additional external exposure from serial CT exposure could be reduced. AIMS: The purpose of this study is to assess the agreement between single CT scanning as CT attenuation Correction with serial CT scanning for serial SPECT imaging as well as estimated absorbed dose to the organ at risk. SETTINGS AND DESIGN: During the first cycle of Lu177-DOTA-TATE, all patients should undergo internal dosimetry technique using SPECT-CT imaging with a PHILIP Brightview XCT gamma camera. The quantifications of SPECT images are being used to measure the uptake activity to the organ. In this investigation, Partik's categorical grading criteria are being used to convert the numeric value of Lin's concordance coefficient into an ordinal scale. METHOD: Total of 9 patients at our institution was administered with Lu177-DOTA-TATE enroll in this study. SPECT-CT data were acquired using automatic body contouring with a total of 48 angular views at steps of 6° (15 s/projections). The pixel size is 4.66 x 4.66 x 4.66 mm, the images size set to one, and SPECT data has been acquired for three-bed positions extending from the abdomen to the thorax region. Low-dose CT imaging performed at an X-ray tube voltage of 120 kVp. RESULTS: Our current result demonstrated by single CT scanning for SPECT attenuation shown the excellent agreement with standard serial CT imaging for organs at risk such as kidney 0.999, spleen 0.9951, liver 0.9951 and bladder 0.9972. CONCLUSIONS: When compared to the previous method, patients benefit significantly more from this study, such as lower CT exposure. Wolters Kluwer - Medknow 2022 2022-08-05 /pmc/articles/PMC9543000/ /pubmed/36212205 http://dx.doi.org/10.4103/jmp.jmp_82_21 Text en Copyright: © 2022 Journal of Medical Physics https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Said, Mohamad Aminudin Bin
Razak, Hairil Rashmizal Abdul
Musarudin, Marianie Bnti
Does Single Computed Tomography Attenuation Correction able to Surrogate Serial Computed Tomography Attenuation Correction in Single-Photon Emission Computed Therapy Imaging for Peptide Receptor Radionuclide Therapy Dosimetry Result?
title Does Single Computed Tomography Attenuation Correction able to Surrogate Serial Computed Tomography Attenuation Correction in Single-Photon Emission Computed Therapy Imaging for Peptide Receptor Radionuclide Therapy Dosimetry Result?
title_full Does Single Computed Tomography Attenuation Correction able to Surrogate Serial Computed Tomography Attenuation Correction in Single-Photon Emission Computed Therapy Imaging for Peptide Receptor Radionuclide Therapy Dosimetry Result?
title_fullStr Does Single Computed Tomography Attenuation Correction able to Surrogate Serial Computed Tomography Attenuation Correction in Single-Photon Emission Computed Therapy Imaging for Peptide Receptor Radionuclide Therapy Dosimetry Result?
title_full_unstemmed Does Single Computed Tomography Attenuation Correction able to Surrogate Serial Computed Tomography Attenuation Correction in Single-Photon Emission Computed Therapy Imaging for Peptide Receptor Radionuclide Therapy Dosimetry Result?
title_short Does Single Computed Tomography Attenuation Correction able to Surrogate Serial Computed Tomography Attenuation Correction in Single-Photon Emission Computed Therapy Imaging for Peptide Receptor Radionuclide Therapy Dosimetry Result?
title_sort does single computed tomography attenuation correction able to surrogate serial computed tomography attenuation correction in single-photon emission computed therapy imaging for peptide receptor radionuclide therapy dosimetry result?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543000/
https://www.ncbi.nlm.nih.gov/pubmed/36212205
http://dx.doi.org/10.4103/jmp.jmp_82_21
work_keys_str_mv AT saidmohamadaminudinbin doessinglecomputedtomographyattenuationcorrectionabletosurrogateserialcomputedtomographyattenuationcorrectioninsinglephotonemissioncomputedtherapyimagingforpeptidereceptorradionuclidetherapydosimetryresult
AT razakhairilrashmizalabdul doessinglecomputedtomographyattenuationcorrectionabletosurrogateserialcomputedtomographyattenuationcorrectioninsinglephotonemissioncomputedtherapyimagingforpeptidereceptorradionuclidetherapydosimetryresult
AT musarudinmarianiebnti doessinglecomputedtomographyattenuationcorrectionabletosurrogateserialcomputedtomographyattenuationcorrectioninsinglephotonemissioncomputedtherapyimagingforpeptidereceptorradionuclidetherapydosimetryresult